a year ago

Relation Therapeutics Secures $35 Million Seed Funding for Osteoporosis Treatment

  • Relation Therapeutics, a London-based biotechnology company, raised $35 million in seed funding, bringing the total amount to $60 million

  • The round was led by DCVC and NVentures with participation from existing investors and new investors like ARK Invest and Deerfield Management Company

  • The company intends to use the funds to advance its osteoporosis pipeline and initiate discovery campaigns in new therapeutic areas.

      • ProblemHealthcare

      "making drug discovery more efficient and effective by combining computational and experimental approaches"

      Solution

      "using a Lab-in-the-Loop approach that integrates single cell multi-omics, functional assays, and machine learning to understand biological processes in human health and disease"

      Covered on